Investors focused on the Medical space have likely heard of Bovie Medical (APYX - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of APYX and the rest of the Medical group's stocks.
Bovie Medical is a member of the Medical sector. This group includes 841 individual stocks and currently holds a Zacks Sector Rank of #1. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. APYX is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past three months, the Zacks Consensus Estimate for APYX's full-year earnings has moved 16.35% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the most recent data, APYX has returned 30.56% so far this year. In comparison, Medical companies have returned an average of 3.44%. As we can see, Bovie Medical is performing better than its sector in the calendar year.
Breaking things down more, APYX is a member of the Medical - Products industry, which includes 77 individual companies and currently sits at #100 in the Zacks Industry Rank. On average, stocks in this group have gained 2.54% this year, meaning that APYX is performing better in terms of year-to-date returns.
Going forward, investors interested in Medical stocks should continue to pay close attention to APYX as it looks to continue its solid performance.